The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
A Leicester doctor tried Mounjaro for obesity and was shocked by how it silenced his 'food noise' and curbed alcohol desires, alongside significant weight loss. But stopping brought cravings back fast. Discover his message on long-term use, side effects, and who should consider it.
A superintendent pharmacist is urging Mounjaro users to take specific precautions when traveling on holiday, from buffet strategies to proper medication storage. Buffets pose unique challenges for GLP-1 users, and extreme temperatures in plane cargo holds can ruin pens. Get expert advice to keep your weight loss journey on track.
On The View, Joy Behar opened up about her GLP-1 weight loss success, noting she was prediabetic before starting. Co-host Sunny Hostin shared gaining 40 lbs during COVID and using Mounjaro to improve her cholesterol from 200 to 140. These stories highlight Hollywood's trend toward Ozempic and similar drugs for real health gains.
New research reveals a stark 'Mounjaro gap' in weight-loss drug access, with middle-class women far more likely to use GLP-1 jabs like Mounjaro privately, deepening class divides. Patients like Kelly Todd face years-long NHS waits despite eligibility. Experts warn this entrenches health inequalities amid high private costs of £144-£324 monthly.
Global food giants like PepsiCo and Coca-Cola are ramping up investments in rebranded, protein-rich products as GLP-1 drugs suppress appetite and alter eating habits across 20% of U.S. households. With potential $12 billion in lost snack sales over the next decade, companies are shifting to smaller portions and nutrient-dense options. This adaptation highlights the lasting ripple effects of obesity medications on the food industry.
On The View, Joy Behar, 83, proudly shared losing 25 lbs on a GLP-1 medication, boasting 'We all did it!' alongside Whoopi Goldberg and guest Savannah Chrisley. The co-hosts opened up about their transformative weight loss experiences with drugs like Ozempic and Mounjaro. This candid discussion highlights the growing popularity of GLP-1s among celebrities.
Indian drugmaker Dr Reddy's Laboratories is gearing up to launch a generic version of Novo Nordisk's Wegovy at prices up to 60% lower than the original. Co-chairman G V Prasad confirmed 50-60% discounts are feasible as semaglutide's patent nears expiry in March. This could reshape access to weight-loss treatments in India's competitive market.
American Made GLP-1 has crowned CoreAge Rx as the best GLP-1 provider for 2026, earning a stellar 4.9 out of 5 rating after reviewing over 10 U.S. telehealth platforms. The 'Editor's Choice' award highlights its FDA-approved semaglutide and tirzepatide programs with board-certified physician oversight. Patients report 10-26% body weight loss in 12 months with personalized care.
American Girl Dolls have undergone a controversial 'Ozempic' makeover, with slimmer bodies aimed at the 'modern era'—but many parents and influencers are far from impressed. The redesign highlights the cultural impact of GLP-1 medications like Ozempic on body ideals. Explore the debate, drug mechanisms, and health considerations.
